| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |